HC
CVS icon

Hamilton Capital’s CVS Health CVS Stock Holding History

Hamilton Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,898
Closed -$391K – 129
2024
Q1 		$391K Sell
4,898
-256
-5% -$19.6K 0.03% 80
2023
Q4 		$407K Sell
5,154
-173
-3% -$12.3K 0.03% 67
2023
Q3 		$372K Buy
5,327
+1,900
+55% +$135K 0.03% 68
2023
Q2 		$237K Sell
3,427
-1,253
-27% -$89.2K 0.02% 99
2023
Q1 		$348K Buy
4,680
+416
+10% +$34.9K 0.02% 71
2022
Q4 		$397K Buy
4,264
+203
+5% +$19.6K 0.03% 74
2022
Q3 		$387K Sell
4,061
-401
-9% -$39.7K 0.03% 48
2022
Q2 		$413K Buy
4,462
+16
+0.4% +$1.56K 0.03% 50
2022
Q1 		$450K Buy
4,446
+1,528
+52% +$161K 0.03% 56
2021
Q4 		$301K Buy
+2,918
New +$270K 0.02% 112

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hamilton Capital's CVS Position: Q2 2024 in Review

Hamilton Capital sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,898 shares — an estimated $391K sold.

Hamilton Capital first reported a position in CVS in Q4 2021 and held it in 10 quarters. The position peaked at $450K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Hamilton Capital reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Hamilton Capital sold 4,898 CVS Health shares in Q2 2024, an estimated $391K.
  • Hamilton Capital first reported a position in CVS Health in Q4 2021 and held it in 10 quarters.
  • Hamilton Capital's CVS Health position peaked at $450K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Hamilton Capital's 13F filing for Q2 2024, filed 14 Aug 2024.